BRIEF-Amarin reaches the onset of about 80 pct of the target aggregate number within the reduce-it study
March 16, 2017 at 06:27 AM EDT
* Amarin reaches the onset of approximately 80% of the target aggregate number of primary major adverse cardiovascular events within the reduce-it study
